Title
DALIRESP® (roflumilast) – For Adults with Severe COPD
Go Home
Category
Description
DALIRESP® (roflumilast) is a prescription medicine used in adults with severe COPD, to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations). Find more information about how DALIRESP can help you.
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon
DALIRESP® (roflumilast) – For Adults with Severe COPD
Page Views
0
Share
Update Time
2022-06-19 18:11:43

"I love DALIRESP® (roflumilast) – For Adults with Severe COPD"

www.daliresp.com VS www.gqak.com

2022-06-19 18:11:43

For US Consumers View Health Care Professional Site Important Safety Information Approved Uses Prescribing Information Medication Guide Navigation HOME UNDERSTANDING SEVERE COPD WHY DALIRESP USING DALIRESP DALIRESP SAVINGS OFFER For adults with severe chronic obstructive pulmonary disease (COPD) to decrease the number of flare-ups Please use the form below to search the website CUT DOWN ON FLARE-UPSMORE TIME FOR CATCH-UPSDALIRESP is a prescription medicine used in adults with severe COPD to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations), pronounced ig-zas-er-BAY-shuns. DALIRESP is not a bronchodilator and should not be used for treating sudden breathing problems. DALIRESP 250 mcg is a starting dose for the first 4 weeks only and is not the effective dose. LEARN ABOUT USING DALIRESPSAVE ON DALIRESP NEXT: UNDERSTANDING SEVERE COPD Back to top IMPORTANT SAFETY INFORMATIONWhat is the most important information I should know about DALIRESP?DALIRESP can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking DALIRESP.DALIRESP may cause mental health problems, including suicidal thoughts and behavior. Some people taking DALIRESP may develop mood or behavior problems, including thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety, new or worse depression, acting on dangerous impulses, or other unusual changes in behavior or moodWeight loss. DALIRESP can cause weight loss. You should check your weight on a regular basis. You will also need to see your healthcare provider regularly to have your weight checked. If you notice that you are losing weight, call your healthcare provider. Your healthcare provider may ask you to stop taking DALIRESP if you lose too much weightDALIRESP may affect the way other medicines work, and other medicines may affect how DALIRESP works. Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements.Who should not take DALIRESP?Do not take DALIRESP if you have certain liver problems. Talk with your healthcare provider before taking DALIRESP if you have liver problems.What should I tell my healthcare provider before taking DALIRESP?Before you take DALIRESP, tell your healthcare provider if you:Have or have had a history of mental health problems, including depression and suicidal behaviorHave liver problemsHave any other medical conditionsAre pregnant or plan to become pregnant. It is not known if DALIRESP will harm your unborn babyAre breastfeeding or plan to breastfeed. It is not known if DALIRESP passes into your breast milkWhat are the most common side effects of DALIRESP?The most common side effects of DALIRESP include diarrhea, weight loss, nausea, headache, back pain, flu-like symptoms, problems sleeping (insomnia), dizziness, and decreased appetite. These are not all the possible side effects of DALIRESP. Always tell your healthcare provider about any side effects that bother you or don't go away.INDICATIONDALIRESP is a prescription medicine used in adults with severe Chronic Obstructive Pulmonary Disease (COPD) to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations). DALIRESP is not a bronchodilator and should not be used for treating sudden breathing problems.DALIRESP 250 mcg is a starting dose for the first 4 weeks only and is not the effective dose.Please see full Prescribing Information, including Medication Guide.You may report side effects related to AstraZeneca products by clicking here. Contact Us AstraZeneca US Corporate Site Privacy Notice Legal Statement Site Map Prescribing Information For US ConsumersDALIRESP is a registered trademark and AZ&Me is a trademark of the AstraZeneca group of companies.©2018 AstraZeneca. All rights reserved. US-19965 Last Updated 9/18